Impact of Implementing the Personalized Non-Pharmacological Therapies Method in Facilities for the Elderly
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorCentre Médical Porte Verte
About this trial
To evaluate, by comparison with the classical method, the effectiveness of using the TNmP method in reducing the intensity or frequency of behavioral disorders in elderly people institutionalized in an institution.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Individuals aged 65 years and older;
Dependent older adults residing in institutional settings, including individuals under legal guardianship or trusteeship, who have been recently admitted to the facility;
Individuals presenting a neurocognitive disorder associated with disruptive cognitive and psychological symptoms (CPS), such as agitation, oppositional behavior, or excessive wandering;
Free and informed consent to participate in the study, signed by the participant or their legal representative.
Disqualifiers
Lack of affiliation to a health insurance or social security scheme;
Life expectancy of less than three months;
Inability to obtain a signed informed consent form from the resident or their legal representative
Trial design
Design model
Single group
Treatments tested in this trial
TNmP
Other interventionTo evaluate the effectiveness of the TNmP method in reducing the intensity and/or frequency of behavioral disturbances by comparing two groups of centers (four using the conventional PNPT selection method and six using the TNmP method).
Treatment groups
226 Participants
are divided into 1 treatment groupGroup A: before/after studyOther 1 intervention
Trial outcomes
Primary outcomes
1
Intensity or frequency of behavioral disorders
The primary outcome measure is to determine whether the use of the TNmP method is associated with greater effectiveness, compared with the conventional method, in reducing the intensity and/or frequency of agitation, resistance to care, or excessive wandering
Time frame
At inclusion and 6 months after inclusionLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: